Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imari Mimura

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Expert Opinion on Pharmacotherapy|June 19, 2024
Evaluating the safety and efficacy of vadadustat for the treatment of anemia associated with chronic kidney diseaseImari Mimura, Tetsuhiro Tanaka, Masaomi Nangaku
Diabetes & Metabolism Journal|January 29, 2021
Treatment of Diabetic Kidney Disease: Current and FutureTomotaka Yamazaki, Imari Mimura, Tetsuhiro Tanaka, et al.
CEN Case Reports|November 8, 2024
A case of PLA2R-positive membranous nephropathy with subsequent development of IgG4-related diseaseFumiaki Tanemoto, Imari Mimura, Hiroyuki Abe, et al.
Kidney International|August 30, 2013
Revolution of nephrology research by deep sequencing: ChIP-seq and RNA-seqImari Mimura, Yasuharu Kanki, Tatsuhiko Kodama, et al.
Kidney International|July 16, 2008
Erythrophagocytosis by renal tubular cellsImari Mimura, Akihiro Tojo, Hiroshi Uozaki, et al.
Journal of the American Society of Nephrology : JASN|January 15, 2015
Epigenetic Changes Induced by Hypoxia-Inducible Factor: a Long Way Still To Go as a Target for Therapy?Masaomi Nangaku, Reiko Inagi, Imari Mimura, et al.
Journal of Pharmacological Sciences|March 23, 2011
Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymesImari Mimura, Tetsuhiro Tanaka, Youichiro Wada, et al.
Nephron|June 9, 2017
Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease TransitionMasaomi Nangaku, Yosuke Hirakawa, Imari Mimura, et al.
Kidney International Supplements|November 18, 2014
Hypoxia and fibrosis in chronic kidney disease: crossing at pericytesTakahisa Kawakami, Imari Mimura, Kumi Shoji, et al.
Physiological Reports|September 14, 2023
Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxiaTomotaka Yamazaki, Imari Mimura, Yu Kurata, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Expert Opinion on Pharmacotherapy|June 19, 2024
Evaluating the safety and efficacy of vadadustat for the treatment of anemia associated with chronic kidney diseaseImari Mimura, Tetsuhiro Tanaka, Masaomi Nangaku
Diabetes & Metabolism Journal|January 29, 2021
Treatment of Diabetic Kidney Disease: Current and FutureTomotaka Yamazaki, Imari Mimura, Tetsuhiro Tanaka, et al.
CEN Case Reports|November 8, 2024
A case of PLA2R-positive membranous nephropathy with subsequent development of IgG4-related diseaseFumiaki Tanemoto, Imari Mimura, Hiroyuki Abe, et al.
Kidney International|August 30, 2013
Revolution of nephrology research by deep sequencing: ChIP-seq and RNA-seqImari Mimura, Yasuharu Kanki, Tatsuhiko Kodama, et al.
Kidney International|July 16, 2008
Erythrophagocytosis by renal tubular cellsImari Mimura, Akihiro Tojo, Hiroshi Uozaki, et al.
Journal of the American Society of Nephrology : JASN|January 15, 2015
Epigenetic Changes Induced by Hypoxia-Inducible Factor: a Long Way Still To Go as a Target for Therapy?Masaomi Nangaku, Reiko Inagi, Imari Mimura, et al.
Journal of Pharmacological Sciences|March 23, 2011
Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymesImari Mimura, Tetsuhiro Tanaka, Youichiro Wada, et al.
Nephron|June 9, 2017
Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease TransitionMasaomi Nangaku, Yosuke Hirakawa, Imari Mimura, et al.
Kidney International Supplements|November 18, 2014
Hypoxia and fibrosis in chronic kidney disease: crossing at pericytesTakahisa Kawakami, Imari Mimura, Kumi Shoji, et al.
Physiological Reports|September 14, 2023
Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxiaTomotaka Yamazaki, Imari Mimura, Yu Kurata, et al.
Pageof 7